Fingerprint
Dive into the research topics of 'Clinical use of tobramycin inhalation solution (TOBI®) shows sustained improvement in FEV1 in cystic fibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Clinical use of tobramycin inhalation solution (TOBI®) shows sustained improvement in FEV1 in cystic fibrosis
Michael W. Konstan, Jeffrey S. Wagener, David J. Pasta, Stefanie J. Millar, Wayne J. Morgan
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations